---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023947"
form_type: "8-K"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:26:30.103683+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma shareholders approve 3M-share increase and evergreen provision in equity plan

## Summary
- Shareholders approved increasing omnibus equity plan shares by 3,000,000 to 4,934,561 total.
- Evergreen provision adopted: automatic annual increase of 5% of outstanding shares on Jan 1 for 10 years from 2025.
- All eight director nominees elected; ratification of KMJ Corbin & Company LLP as auditor passed.
- Meeting had 70.4% of shares present, constituting a quorum.

## SEC filing metadata
- accession: 0001493152-24-023947
- form_type: 8-K
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/0001493152-24-023947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023947
- JSON: https://secwatch.observer/filing/0001493152-24-023947.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023947.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.